关于 depo-provera 的可接受性

Isotropy of Cosmic Rays beyond 10^{20} eV Favors Their Heavy Mass Composition.

Physical review letters·2024

An extremely energetic cosmic ray observed by a surface detector array.

Science (New York, N.Y.)·2023

Tumor Embolization through Meningohypophyseal and Inferolateral Trunks is Safe and Effective.

AJNR. American journal of neuroradiology·2022

Identifying critical source areas using multiple methods for effective diffuse pollution mitigation.

Journal of environmental management·2019

Using medico-legal claims for quality improvement in maternity care: application and revision of an NHSLA coding taxonomy.

BJOG : an international journal of obstetrics and gynaecology·2019

Nitrogen fixation (acetylene reduction) associated with communities of heterocystous and non-heterocystous blue-green algae in mangrove forests of Sinai.

Oecologia·2017

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

AI product liability under EU and Canadian laws.

Frontiers in artificial intelligence·2026

[THE ACTUAL ISSUES OF MANDATORY LABELING OF MEDICAL ARTICLES].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2026

Pharmaceutical Innovation and Drug Policy: The Case of the 1984 Hatch-Waxman Act.

PloS one·2026

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies.

Neurourology and urodynamics·2026

Decreased Gabapentin Prescription Fills Among Medicaid Enrollees Following State-Level Schedule V Controlled Substance Classification in Kentucky and West Virginia.

Substance use & addiction journal·2026

Contraindications of femoral implants in primary total hip arthroplasty : legal implications and strategies for orthopaedic surgeons.

Bone & joint open·2026

相关实验视频

关于 depo-provera 的可接受性

相关概念视频

Isotropy of Cosmic Rays beyond 10^{20} eV Favors Their Heavy Mass Composition.

An extremely energetic cosmic ray observed by a surface detector array.

Tumor Embolization through Meningohypophyseal and Inferolateral Trunks is Safe and Effective.

Identifying critical source areas using multiple methods for effective diffuse pollution mitigation.

Using medico-legal claims for quality improvement in maternity care: application and revision of an NHSLA coding taxonomy.

Nitrogen fixation (acetylene reduction) associated with communities of heterocystous and non-heterocystous blue-green algae in mangrove forests of Sinai.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

AI product liability under EU and Canadian laws.

[THE ACTUAL ISSUES OF MANDATORY LABELING OF MEDICAL ARTICLES].

Pharmaceutical Innovation and Drug Policy: The Case of the 1984 Hatch-Waxman Act.

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies.

Decreased Gabapentin Prescription Fills Among Medicaid Enrollees Following State-Level Schedule V Controlled Substance Classification in Kentucky and West Virginia.

Contraindications of femoral implants in primary total hip arthroplasty : legal implications and strategies for orthopaedic surgeons.

相关实验视频

关于 depo-provera 的可接受性

相关概念视频

相关文章